Polycystic Ovary Syndrome Supplements Market To Reach $3.80 Billion By 2033

Polycystic Ovary Syndrome Supplements Market Growth & Trends

The global polycystic ovary syndrome supplements market size is projected to reach USD 3.80 billion by 2033, growing at a CAGR of 14.29% from 2025 to 2033, according to a new report by Grand View Research, Inc. The industry is experiencing robust growth, driven by the rising prevalence of Polycystic Ovary Syndrome (PCOS) and increasing awareness among women of reproductive age. With an estimated 6–13% of women affected worldwide, improved diagnostics and heightened understanding of the condition are prompting more women to seek effective management options. This has created strong demand for supplements that support hormonal balance, menstrual regularity, and fertility. Companies like Theralogix and The S’moo Co. actively address this need by offering clinically supported and user-friendly products tailored to this growing patient population.

A key driver of market expansion is the preference for natural and evidence-based solutions. Ingredients such as myo-inositol, D-chiro inositol, vitamin D, and omega-3 fatty acids are increasingly sought due to their proven efficacy in managing insulin resistance, hormonal imbalance, and ovulatory dysfunction. Theralogix, for example, has leveraged clinical validation with its flagship product Ovasitol, offering a myo- and D-chiro inositol combination in a clinically supported ratio. At the same time, The S’moo Co. emphasizes clean, plant-based formulations that appeal to consumers seeking safe, natural alternatives to conventional therapies.

The growth of e-commerce and direct-to-consumer distribution channels further fuels market expansion. Online platforms enable consumers to access various PCOS supplements, receive personalized recommendations, and benefit from subscription models for long-term adherence. Brands like The S’moo Co. and Himalaya Wellness have strengthened their digital presence to reach broader audiences, offering convenient purchasing options and enhancing customer engagement. These factors, rising prevalence, preference for natural solutions, and expanding digital access, drive sustained growth and innovation in the PCOS supplements market.

 Request a free sample copy or view report summary: Polycystic Ovary Syndrome Supplements Market Report

Polycystic Ovary Syndrome Supplements Market Report Highlights

• By ingredient, Myo?inositol-based supplements dominated the market, with the largest revenue share of 41.81% in 2024, due to their well-documented clinical benefits in improving insulin sensitivity, restoring ovulatory cycles, and supporting hormonal balance.

• By dosage form, the gummies segment is expected to grow at a significant CAGR over the forecast period. Gummies are emerging as a strong driver in the PCOS supplements market, appealing to younger consumers and those seeking a more enjoyable, convenient alternative to pills.

• By indication, the hormonal regulation segment led the PCOS supplements industry in 2024, accounting for the largest revenue share of 33.83%. This dominance is driven by the high demand for supplements that balance estrogen and androgen levels, addressing key PCOS symptoms like irregular cycles, acne, and hirsutism.

• By sales channel, the pharmacy & drug stores segment is projected to grow at a significant CAGR during the forecast period, driven by providing trusted, easily accessible points of purchase for consumers seeking reliable and regulated products.

Polycystic Ovary Syndrome Supplements Market Segmentation

Grand View Research has segmented the global polycystic ovary syndrome (PCOS) supplements market on the basis of ingredient, dosage form, indication, sales channel, and region.

Polycystic Ovary Syndrome (PCOS) Supplements Ingredient Outlook (Revenue, USD Million, 2021 - 2033)

• Myo?inositol-based supplements

• Micronutrient & Omega-3

• Herbal Supplements

• Others

Polycystic Ovary Syndrome (PCOS) Supplements Dosage Form Outlook (Revenue, USD Million, 2021 - 2033)

• Capsules & tablets

• Powders

• Gummies

• Liquids

Polycystic Ovary Syndrome (PCOS) Supplements Indication Outlook (Revenue, USD Million, 2021 - 2033)

• Menstrual Cycle Support

• Hormonal Regulation

• Fertility Improvement

• Acne and Skin Health

• Others

Polycystic Ovary Syndrome (PCOS) Supplements Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)

• Hypermarket & Supermarket

• Pharmacy & Drug stores

• Online Stores

Polycystic Ovary Syndrome (PCOS) Supplements Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Polycystic Ovary Syndrome Supplements Market

• Himalaya Wellness

• Theralogix

• Allara Health

• The S’moo Co.

• Fertility Family

• SOVA

• MyOva

• Black Girl Vitamins

• New Leaf Products

• Zazzee Naturals